Biểu đồ giá cổ phiếu FBRX
FBRX Cổ tức
Forte Biosciences Inc
$76.5
39.64%
$21.72
Khi đóng cửa: Jul 27, 16:00:00 GMT-4
$76.51
0.01%
$0.01
Phiên trước giờ: Jul 28, 09:41:50 GMT-4
Quay lại
Forte Biosciences Inc (FBRX) Cổ tức
Thống kê chính
Giá đóng cửa trước
$54.78
Giá mở cửa
$76.41
Phạm vi ngày
$76.39 - $76.58
Phạm vi 52 tuần
$9.1 - $76.51
Khối lượng
17.1M
Khối lượng trung bình
315.2K
Tỷ suất cổ tức
--
EPS (TTM)
-4.58
Vốn hóa thị trường
$1.5B
FBRX là gì?
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The company is headquartered in Dallas, Texas and currently employs 19 full-time employees. The company went IPO on 2017-04-13. The company is advancing clinical development of FB102 into patient-based trials for celiac disease and non-segmental vitiligo. The firm's FB102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and certain T cell subsets. FB102 has potentially other autoimmune and autoimmune-related applications including vitiligo, alopecia areata, and type 1 diabetes (T1D). Its subsidiaries include Forte Subsidiary, Inc. and Forte Biosciences Australia Proprietary Limited.
